Display options
Cite
Lawson JS, Glenn WK, Salyakina D, et al. Human Papilloma Virus Identification in Breast Cancer Patients with Previous Cervical Neoplasia. Front Oncol. 2016;5:298doi: 10.3389/fonc.2015.00298.
Lawson, J. S., Glenn, W. K., Salyakina, D., Clay, R., Delprado, W., Cheerala, B., Tran, D. D., Ngan, C. C., Miyauchi, S., Karim, M., Antonsson, A., & Whitaker, N. J. (2015). Human Papilloma Virus Identification in Breast Cancer Patients with Previous Cervical Neoplasia. Frontiers in oncology, 5298. https://doi.org/10.3389/fonc.2015.00298
Lawson, James S, et al. "Human Papilloma Virus Identification in Breast Cancer Patients with Previous Cervical Neoplasia." Frontiers in oncology vol. 5 (2015): 298. doi: https://doi.org/10.3389/fonc.2015.00298
Lawson JS, Glenn WK, Salyakina D, Clay R, Delprado W, Cheerala B, Tran DD, Ngan CC, Miyauchi S, Karim M, Antonsson A, Whitaker NJ. Human Papilloma Virus Identification in Breast Cancer Patients with Previous Cervical Neoplasia. Front Oncol. 2016 Jan 08;5:298. doi: 10.3389/fonc.2015.00298. eCollection 2015. PMID: 26779441; PMCID: PMC4705232.
Copy Download .nbib Format: NLM
Share it on

Front Oncol. 2016 Jan 08;5:298. doi: 10.3389/fonc.2015.00298. eCollection 2015.

Human Papilloma Virus Identification in Breast Cancer Patients with Previous Cervical Neoplasia.

Frontiers in oncology

James S Lawson, Wendy K Glenn, Daria Salyakina, Rosemary Clay, Warick Delprado, Bharathi Cheerala, Dinh D Tran, Christopher C Ngan, Shingo Miyauchi, Martha Karim, Annika Antonsson, Noel J Whitaker

Affiliations

  1. School of Biotechnology and Biomolecular Science, University of New South Wales , Sydney, NSW , Australia.
  2. Center for Computational Science, University of Miami , Miami, FL , USA.
  3. Douglass Hanly Moir?-?Pathology , Macquarie Park, NSW , Australia.
  4. QIMR Berghofer Medical Research Institute , Brisbane, QLD , Australia.

PMID: 26779441 PMCID: PMC4705232 DOI: 10.3389/fonc.2015.00298

Abstract

PURPOSE: Women with human papilloma virus (HPV)-associated cervical neoplasia have a higher risk of developing breast cancer than the general female population. The purpose of this study was to (i) identify high-risk HPVs in cervical neoplasia and subsequent HPV positive breast cancers which developed in the same patients and (ii) determine if these HPVs were biologically active.

METHODS: A range of polymerase chain reaction and immunohistochemical techniques were used to conduct a retrospective cohort study of cervical precancers and subsequent breast cancers in the same patients.

RESULTS: The same high-risk HPV types were identified in both the cervical and breast specimens in 13 (46%) of 28 patients. HPV type 18 was the most prevalent. HPVs appeared to be biologically active as demonstrated by the expression of HPV E7 proteins and the presence of HPV-associated koilocytes. The average age of these patients diagnosed with breast cancer following prior cervical precancer was 51 years, as compared to 60 years for all women with breast cancer (p for difference = 0.001).

CONCLUSION: These findings indicate that high-risk HPVs can be associated with cervical neoplasia and subsequent young age breast cancer. However, these associations are unusual and are a very small proportion of breast cancers. These outcomes confirm and extend the observations of two similar previous studies and offer one explanation for the increased prevalence of serious invasive breast cancer among young women.

Keywords: breast cancer; cervical neoplasia; human papilloma viruses; young age

References

  1. JAMA. 2013 Feb 27;309(8):800-5 - PubMed
  2. Nature. 2013 Feb 21;494(7437):366-70 - PubMed
  3. Br J Cancer. 2009 Oct 20;101(8):1351-6 - PubMed
  4. BMC Infect Dis. 2013 Dec 16;13:593 - PubMed
  5. Appl Immunohistochem Mol Morphol. 2013 Jul;21(4):341-50 - PubMed
  6. PLoS One. 2014 May 23;9(5):e97787 - PubMed
  7. Int J Cancer. 2008 Apr 1;122(7):1684-5 - PubMed
  8. Dis Markers. 2013;35(6):607-13 - PubMed
  9. BMC Cancer. 2014 Jul 21;14:529 - PubMed
  10. Br J Cancer. 2008 Aug 5;99(3):408-14 - PubMed
  11. Breast Cancer Res Treat. 2012 Aug;135(1):1-15 - PubMed
  12. Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):2080-7 - PubMed
  13. J Clin Virol. 2004 Dec;31(4):292-7 - PubMed
  14. Virology. 2003 Feb 15;306(2):197-202 - PubMed
  15. Br J Cancer. 2009 Oct 20;101(8):1345-50 - PubMed
  16. J Mol Diagn. 2011 Jul;13(4):377-81 - PubMed
  17. Prostate. 2013 Feb 15;73(3):236-41 - PubMed
  18. Semin Oncol. 2015 Apr;42(2):247-57 - PubMed
  19. Breast Cancer Res Treat. 1999 Jan;53(2):121-35 - PubMed
  20. J Virol. 2015 Apr;89(8):4051-7 - PubMed
  21. Breast Cancer Res Treat. 2012 May;133(1):169-77 - PubMed
  22. BMC Med. 2011 Sep 13;9:104 - PubMed
  23. Nat Commun. 2013;4:2513 - PubMed
  24. Br J Cancer. 2012 Oct 23;107(9):1451-3 - PubMed
  25. PLoS One. 2012;7(11):e48788 - PubMed
  26. Virology. 1996 Mar 1;217(1):392-6 - PubMed

Publication Types